Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Q12021
17 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Lyophilization
Shorten Time to Market with New Data-Driven Lyophilization Process
PAO-03-21-CL-07
Clinical Trial Logistics
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
PAO-03-21-CL-06
Business Development
Q: How are you growing your business development activities in the absence of conventional trade shows and other traditional business development/marketing activities?
PAO-03-21-NI-02
COVID-19 Impacts
Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?
PAO-03-21-NI-01
Tissue Models
Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine
PAO-03-21-CL-01
Facility Design
Cell Therapy Facility Design Synopsis: Horizontal vs. Vertical
PAO-03-21-CL-02
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
PAO-02-21-CL-04
Process Intensification
Factory of the Future Will Be a Convergence of Digital and Bioprocessing Technologies
PAO-02-21-CL-03
Nitrosamine
Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations
PAO-02021-CL-05
Chemistry, Manufacturing, and Controls
Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization
PAO-01-21-CL-05
Cell Therapy
Economically Viable, Same-Day Autologous Cell Therapies
PAO-01-21-CL-06
Tissue Models
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
PAO-02-21-CL-01
Process Development
Innovative Approach to Process Development
PAO-02-21-CL-02
Gene Therapy
Beyond 2020: Looking into the Crystal Ball for Gene Therapy
PAO-01-21-CL-03
Tissue Models
The Power of RepliGut In Vitro Intestinal Stem Cell Models
HPAPI
A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs
PAO-01-21-CL-01
Cell Therapy
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
PAO-12-20-CL-01
